The combination of tumor-associated Neu5Gc and our circulating  anti-Neu5Gc autoantibodies promotes tumor growth, by inducing weak inflammation, causing infiltration of inflammatory cells and  enhancing angiogenesis, enhanced blood flow to the tumor. 